Can this agreement be signed electronically?

Yes. Electronic signatures are enforceable under the ESIGN Act (15 U.S.C. ch. 96) and UETA in most states. For patient-facing clinical records, ensure the consumer disclosure and consent process is documented and a HIPAA BAA is in place with the vendor.

Is notarization required for consent?

Not typically for routine medication consent. Some states or specific institutional policies may require notarization or witnesses; check state rules and facility policies before requiring notarization.

Who signs for minors or incapacitated patients?

A parent or legally authorized representative signs for minors or incapacitated patients. Document the representative's authority and retain supporting documentation in the chart.

How do I correct a signed agreement?

Do not alter a signed document. Prepare an addendum or corrected agreement, have all parties sign and date the new document, and retain the original for audit trail integrity.

What if patient details are wrong?

If demographic or medical information is incorrect, correct the record with an addendum noting the correction, date, and who made the change to preserve an audit trail.

How long until the agreement is processed?

Processing time varies by practice; electronically captured signatures are available immediately, but prior authorization or pharmacy verification can add 1–5 business days.

Electronic Signature
Templates
Healthcare
Healthcare Patient Agreement for PA Intuniv

Healthcare Patient Agreement for PA Intuniv

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

PATIENT AGREEMENT FOR PA INTUNIV

Patient Information

Patient Full Legal Name

Date of Birth:

Gender:

Preferred Pronouns:

Address

Primary Phone:

Email:

Emergency Contact

Name

Relationship:

Phone:

Insurance Information

Primary Insurance Provider

Policy / ID #:

Group #:

Subscriber Name:

Medical History

Current Medications (include dosage and frequency) Allergies / Adverse Reactions Relevant Surgical / Medical History

Has the patient been diagnosed with any of the following? (check all that apply) ADHD Hypertension Cardiac disease Hepatic impairment Other

Medication Authorization and Treatment Plan

I hereby authorize the Physician Assistant (PA) and clinical staff to prescribe and manage guanfacine extended-release (Intuniv) as part of my treatment plan. The proposed indication: . The initial dose, titration plan, and maintenance dosing will be determined by the PA based upon clinical assessment and monitoring.

Planned Initial Dose / Titration Instructions

I understand that Intuniv is a medication that may cause drowsiness, dizziness, hypotension, bradycardia, and changes in behavior. I acknowledge that I have been informed of common and serious potential adverse effects, including but not limited to sedation, low blood pressure, fainting, slow heart rate, mood changes, and possible interactions with other central nervous system depressants or antihypertensive agents.

Risks, Benefits and Alternatives

The PA has explained the expected benefits of treatment with Intuniv, which may include improved attention, decreased impulsivity, and improved behavioral control. The PA has also explained reasonable alternatives, including behavior therapy, other pharmacologic treatments, or no medication. I understand that no guarantee has been made regarding the outcome of this treatment.

I understand the following important advisories: do not abruptly discontinue Intuniv without medical advice; avoid excessive alcohol or other sedating substances while taking Intuniv; inform the PA promptly if experiencing symptoms of low blood pressure (lightheadedness, fainting), syncope, significant drowsiness, or cardiac symptoms. If pregnant, planning pregnancy, or breastfeeding, inform the PA prior to initiating treatment.

Is the patient currently pregnant or breastfeeding? Yes No Unknown

Monitoring and Follow-Up

I agree to adhere to clinical monitoring recommended by the PA, which may include periodic assessment of blood pressure and heart rate, evaluation of side effects, and documentation of functional response. I understand that dosing adjustments may be necessary and that the PA may discontinue treatment if risks outweigh benefits.

Monitoring Plan / Follow-up Schedule

HIPAA Authorization and Medical Record Release

I authorize the PA and clinical staff to disclose my relevant health information to pharmacies, consultants, and other healthcare providers as necessary for safe treatment with Intuniv. I acknowledge receipt of the practice's Notice of Privacy Practices and understand my rights to request restrictions on disclosures as permitted by law.

Pharmacy Name / Preferred Pharmacy Authorization Expiration Date

Financial Responsibility

I understand that I am financially responsible for charges associated with visits, medication management, and any services provided even if payment is sought from an insurance carrier. I authorize insurance benefits to be paid to the treating practice when applicable.

Patient Acknowledgments and Consent

By signing below I certify that I have read (or had read to me) and understand the information contained in this Patient Agreement for PA Intuniv. I have had the opportunity to ask questions and they have been answered to my satisfaction. I consent to treatment and medication management by the PA as described in this agreement. I understand I may withdraw this consent at any time by notifying the practice in writing.

Additional Patient Notes or Questions

Patient Name:

Signature:

Date:

If signed by parent or guardian, relationship to patient: If signing on patient's behalf, the signer warrants they have legal authority to consent to treatment.

What the Healthcare Patient Agreement for PA Intuniv covers

The Healthcare Patient Agreement for PA Intuniv documents informed consent, medication instructions, monitoring plans, and mutual responsibilities when a physician assistant prescribes Intuniv (guanfacine extended-release). It records patient medical history, known allergies, dosing regimen, follow-up schedule, and emergency instructions. The form also includes data-sharing acknowledgments and HIPAA-related authorizations for treatment and communication. When completed and signed, the agreement creates a clear record of clinical decisions and patient commitments to support safe, compliant medication management.

Why a clear patient agreement matters for Intuniv prescriptions

A written agreement reduces clinical ambiguity, documents consent, and outlines monitoring and refill expectations. It supports safer prescribing, clarifies responsibilities, and provides a defensible record in the event of questions about adherence or adverse events.

Who typically completes and relies on this agreement

The agreement is completed by a clinician and signed by the patient (or authorized representative) to document treatment terms and consent.

Prescribing clinician and clinical staff — prepare and explain the agreement to the patient before initiating therapy.
Patients or guardians — read, ask questions, and sign to acknowledge understanding and consent to treatment.
Pharmacies and payers — use the completed agreement when verifying dosing, prior authorization, or dispensing requirements.

It is retained in the patient chart and may be shared with pharmacies, payers, or other treating providers under applicable privacy rules.

Typical signers and their roles

Physician Assistant

A licensed PA who prescribes Intuniv completes clinical sections, documents rationale, and certifies monitoring plans. The PA documents review of history, current medications, and contraindications, and confirms that patient education was provided.

Patient or Guardian

The patient or an authorized guardian signs to confirm receipt of medication instructions, consent to treatment, and agreement to follow monitoring and refill procedures. The signer accepts responsibility for reporting side effects and attending follow-up appointments.

Core elements to include in a professional patient agreement

A complete agreement balances clinical detail with clear patient-facing language. Include medication specifics, consent language, monitoring expectations, privacy notices, and signature blocks to create a concise legal and medical record.

Medication Details

Clearly state drug name (Intuniv), formulation, dose, frequency, route, and special instructions such as take with or without food and dose timing relative to school or work.

Indications and Rationale

Describe the clinical reason for prescribing Intuniv, intended therapeutic goals, and how effectiveness will be measured during follow-up visits.

Side Effects and Emergency

List common and serious side effects, when to stop the medication, and specific emergency instructions including when to seek urgent care.

Monitoring Plan

Define scheduled follow-ups, vital sign checks, behavioral monitoring, and any laboratory or symptom-tracking required to evaluate safety and efficacy.

Privacy & Data Use

Include HIPAA-compliant authorization language for treatment-related communications and any third-party disclosures required for care coordination or payer submissions.

Signatures & Dates

Provide signature lines for the patient, prescriber (PA), and witness or guardian as required, with dated fields to record when consent was given.

Step-by-step: completing the patient agreement

Follow these sequential actions to prepare, review, and finalize the Healthcare Patient Agreement for PA Intuniv with a patient.

01

Prepare the form: Populate patient demographics and clinical fields before the visit.
02

Discuss treatment: Explain benefits, risks, and monitoring in plain language; answer patient questions.
03

Sign and date: Obtain signatures from patient/guardian and prescriber with dated entries.
04

Store in record: Save the signed agreement to the EHR and provide a copy to the patient.

Typical electronic workflow for eSigning and storage

A standard eSignature workflow reduces physical paperwork while maintaining an audit trail for clinical and legal needs.

Sender uploads: Clinician uploads form to an eSignature platform in PDF or DOCX format.
Fields placed: Signature, date, and initial fields are added to the document.
Patient signs: Patient authenticates and signs via email link or secure portal.
Archive and audit: Signed file and audit trail are stored in the EHR or encrypted cloud.

Recommended eSubmission settings for clinical workflows

Configure your electronic workflow to match clinical needs: authentication strength, templating, and secure storage.

Field	Configuration
Authentication Method	Email link plus SMS code for patient identity verification
Template Defaults	Pre-fill demographics from EHR to reduce entry errors
Signing Order	Patient signs first, then prescriber confirms and countersigns
Storage Location	Encrypted PDF stored in EHR and secure cloud backup

Technical requirements and integration considerations

Ensure the signing platform supports secure storage, audit trails, and formats accepted by your EHR and pharmacy partners.

File formats: PDF and DOCX are widely supported for signed records.
Integrations: EHR and pharmacy interfaces reduce manual uploads and errors.
Access control: MFA and role-based permissions protect PHI access.

Typical timeframes to manage after signing

Track these customary timelines to ensure timely monitoring, refills, and documentation following initial consent and prescription.

Effective Date:

Date the agreement takes effect; recorded as MM/DD/YYYY

Initial Follow-Up:

Often scheduled within 1–4 weeks to check tolerance and response

Medication Review:

Conduct formal review every 3–6 months or per clinical judgment

Refill Authorization Window:

Process refill requests 3–7 business days before supply ends

Consent Renewal:

Re-evaluate and re-document consent if treatment changes materially

Key processing milestones from intake to follow-up

These numbered milestones outline the sequential stages required to finalize treatment and ensure ongoing monitoring.

01

Intake and Assessment

Collect history, allergies, and baseline measures before prescribing

02

Consent Execution

Patient signs the agreement and acknowledges risks and monitoring

03

Medication Initiation

Begin Intuniv at prescribed dose with clear titration plan

04

Ongoing Review

Monitor effectiveness and side effects at defined intervals

Common preparation errors to avoid

Incomplete allergy or medication history increases risk of adverse drug interactions and gaps in safety monitoring.
Incorrect dates or mismatched names between the agreement and pharmacy profile can delay dispensing or create billing issues.
Omitting explicit monitoring intervals leads to missed follow-ups and unclear responsibility for side-effect reporting.
Using unsecured email to send PHI exposes the practice to privacy breaches and potential HIPAA violations.

Security and compliance elements to document

HIPAA: BAA required

Encryption: TLS 1.2/1.3, AES-256

Audit Trail: Timestamp and IP logging

21 CFR Part 11: Compliant options

SOC 2: Type II certified

Access Controls: MFA and role-based

Potential risks and consequences of errors

Medication Error: Adverse event risk

Missing Consent: Legal exposure

HIPAA Violation: Fines and corrective action

Insurance Denial: Claim or prior auth refusal

Delays in Care: Treatment interruptions

Invalid Signature: Document unenforceable

eSignature vendor comparison for clinical agreements

Platform pricing and core capabilities vary. The table below summarizes starting prices and common features relevant to healthcare patient agreements and HIPAA compliance.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day free trial	Varies	Varies	Varies	Varies
Bulk Send	Yes (Business Premium)	Varies	Varies	Varies	Varies
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No

Frequently asked questions about the patient agreement and eSigning

Answers to common operational and legal questions about executing, storing, and updating the Healthcare Patient Agreement for PA Intuniv.

Need help? Contact support

Can this agreement be signed electronically?
Yes. Electronic signatures are enforceable under the ESIGN Act (15 U.S.C. ch. 96) and UETA in most states. For patient-facing clinical records, ensure the consumer disclosure and consent process is documented and a HIPAA BAA is in place with the vendor.
Is notarization required for consent?
Not typically for routine medication consent. Some states or specific institutional policies may require notarization or witnesses; check state rules and facility policies before requiring notarization.
Who signs for minors or incapacitated patients?
A parent or legally authorized representative signs for minors or incapacitated patients. Document the representative's authority and retain supporting documentation in the chart.
How do I correct a signed agreement?
Do not alter a signed document. Prepare an addendum or corrected agreement, have all parties sign and date the new document, and retain the original for audit trail integrity.
What if patient details are wrong?
If demographic or medical information is incorrect, correct the record with an addendum noting the correction, date, and who made the change to preserve an audit trail.
How long until the agreement is processed?
Processing time varies by practice; electronically captured signatures are available immediately, but prior authorization or pharmacy verification can add 1–5 business days.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now